A mouse model for fucosidosis recapitulates storage pathology and neurological features of the milder form of the human disease

Wolf H, Damme M, Stroobants S, D'Hooge R, Beck HC, Hermans-Borgmeyer I, Lüllmann-Rauch R, Dierks T, Lübke T (2016)
Disease Models & Mechanisms 9(9): 1015-1028.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
OA 4.54 MB
Wolf, HeikeUniBi; Damme, MarkusUniBi; Stroobants, Stijn; D'Hooge, Rudi; Beck, Hans Christian; Hermans-Borgmeyer, Irm; Lüllmann-Rauch, Renate; Dierks, ThomasUniBi; Lübke, TorbenUniBi
Abstract / Bemerkung
Fucosidosis is a rare lysosomal storage disorder caused by the inherited deficiency of the lysosomal hydrolase α-L-fucosidase, which leads to an impaired degradation of fucosylated glycoconjugates. Here, we report the generation of a fucosidosis mouse model, in which the gene for lysosomal α-L-fucosidase (Fuca1) was disrupted by gene targeting. Homozygous knockout mice completely lack α-L-fucosidase activity in all tested organs leading to highly elevated amounts of the core-fucosylated glycoasparagine Fuc (α1,6)-GlcNAc(β1-N)-Asn and, to a lesser extent, other fucosylated glycoasparagines, which all were also partially excreted in urine. Lysosomal storage pathology was observed in many visceral organs, such as in the liver, kidney, spleen and bladder, as well as in the central nervous system (CNS). On the cellular level, storage was characterized by membrane-limited cytoplasmic vacuoles primarily containing water-soluble storage material. In the CNS, cellular alterations included enlargement of the lysosomal compartment in various cell types, accumulation of secondary storage material and neuroinflammation, as well as a progressive loss of Purkinje cells combined with astrogliosis leading to psychomotor and memory deficits. Our results demonstrate that this new fucosidosis mouse model resembles the human disease and thus will help to unravel underlying pathological processes. Moreover, this model could be utilized to establish diagnostic and therapeutic strategies for fucosidosis.
Fucosidosis; Neurodegeneration; Lysosomal storage disorder
Disease Models & Mechanisms
1754-8403, 1754-8411
Open-Access-Publikationskosten wurden durch die Deutsche Forschungsgemeinschaft und die Universität Bielefeld gefördert.
Page URI


Wolf H, Damme M, Stroobants S, et al. A mouse model for fucosidosis recapitulates storage pathology and neurological features of the milder form of the human disease. Disease Models & Mechanisms. 2016;9(9):1015-1028.
Wolf, H., Damme, M., Stroobants, S., D'Hooge, R., Beck, H. C., Hermans-Borgmeyer, I., Lüllmann-Rauch, R., et al. (2016). A mouse model for fucosidosis recapitulates storage pathology and neurological features of the milder form of the human disease. Disease Models & Mechanisms, 9(9), 1015-1028. doi:10.1242/dmm.025122
Wolf, H., Damme, M., Stroobants, S., D'Hooge, R., Beck, H. C., Hermans-Borgmeyer, I., Lüllmann-Rauch, R., Dierks, T., and Lübke, T. (2016). A mouse model for fucosidosis recapitulates storage pathology and neurological features of the milder form of the human disease. Disease Models & Mechanisms 9, 1015-1028.
Wolf, H., et al., 2016. A mouse model for fucosidosis recapitulates storage pathology and neurological features of the milder form of the human disease. Disease Models & Mechanisms, 9(9), p 1015-1028.
H. Wolf, et al., “A mouse model for fucosidosis recapitulates storage pathology and neurological features of the milder form of the human disease”, Disease Models & Mechanisms, vol. 9, 2016, pp. 1015-1028.
Wolf, H., Damme, M., Stroobants, S., D'Hooge, R., Beck, H.C., Hermans-Borgmeyer, I., Lüllmann-Rauch, R., Dierks, T., Lübke, T.: A mouse model for fucosidosis recapitulates storage pathology and neurological features of the milder form of the human disease. Disease Models & Mechanisms. 9, 1015-1028 (2016).
Wolf, Heike, Damme, Markus, Stroobants, Stijn, D'Hooge, Rudi, Beck, Hans Christian, Hermans-Borgmeyer, Irm, Lüllmann-Rauch, Renate, Dierks, Thomas, and Lübke, Torben. “A mouse model for fucosidosis recapitulates storage pathology and neurological features of the milder form of the human disease”. Disease Models & Mechanisms 9.9 (2016): 1015-1028.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Copyright Statement:
Dieses Objekt ist durch das Urheberrecht und/oder verwandte Schutzrechte geschützt. [...]
Access Level
OA Open Access
Zuletzt Hochgeladen
MD5 Prüfsumme

2 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Sensorimotor and Neurocognitive Dysfunctions Parallel Early Telencephalic Neuropathology in Fucosidosis Mice.
Stroobants S, Wolf H, Callaerts-Vegh Z, Dierks T, Lübke T, D'Hooge R., Front Behav Neurosci 12(), 2018
PMID: 29706874
Transcriptomic analysis of FUCA1 knock-down in keratinocytes reveals new insights into the pathogenesis of fucosidosis skin lesions.
Valero-Rubio D, Jiménez KM, Fonseca DJ, Payán-Gómez C, Laissue P., Exp Dermatol 27(6), 2018
PMID: 29518279

65 References

Daten bereitgestellt von Europe PubMed Central.

The enzymic defect and storage products in canine fucosidosis.
Abraham D, Blakemore WF, Dell A, Herrtage ME, Jones J, Littlewood JT, Oates J, Palmer AC, Sidebotham R, Winchester B., Biochem. J. 222(1), 1984
PMID: 6477509
Cognition and hippocampal synaptic plasticity in mice with a homozygous tau deletion.
Ahmed T, Van der Jeugd A, Blum D, Galas MC, D'Hooge R, Buee L, Balschun D., Neurobiol. Aging 35(11), 2014
PMID: 24913895
Fucosidosis in a domestic shorthair cat.
Arrol LP, Kerrins AM, Yamakawa Y, Smith PM., J. Feline Med. Surg. 13(2), 2010
PMID: 21115380
Lysosomal disorders: from storage to cellular damage.
Ballabio A, Gieselmann V., Biochim. Biophys. Acta 1793(4), 2008
PMID: 19111581
Phenotypic spectrum of fucosidosis in Tunisia.
Ben Turkia H, Tebib N, Azzouz H, Abdelmoula MS, Bouguila J, Sanhaji H, Miladi N, Maire I, Caillaud C, Kaabachi N, Ben Dridi MF., J. Inherit. Metab. Dis. 31 Suppl 2(), 2008
PMID: 18651239
Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease.
Bijvoet AG, van de Kamp EH, Kroos MA, Ding JH, Yang BZ, Visser P, Bakker CE, Verbeet MP, Oostra BA, Reuser AJ, van der Ploeg AT., Hum. Mol. Genet. 7(1), 1998
PMID: 9384603
Fucosidosis: a neuropathological study.
Bugiani O, Borrone C., Riv Patol Nerv Ment 97(3), 1976
PMID: 1032031
Rapid preparation of a distinct lysosomal population from myelinating mouse brain using Percoll gradients.
Caimi L, Marchesini S, Aleo MF, Bresciani R, Monti E, Casella A, Giudici ML, Preti A., J. Neurochem. 52(6), 1989
PMID: 2542449
Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D.
Claussen M, Kubler B, Wendland M, Neifer K, Schmidt B, Zapf J, Braulke T., Endocrinology 138(9), 1997
PMID: 9275067
Cerebellar alterations and gait defects as therapeutic outcome measures for enzyme replacement therapy in α-mannosidosis.
Damme M, Stroobants S, Walkley SU, Lullmann-Rauch R, D'Hooge R, Fogh J, Saftig P, Lubke T, Blanz J., J. Neuropathol. Exp. Neurol. 70(1), 2011
PMID: 21157375
Chronic enzyme replacement therapy ameliorates neuropathology in alpha-mannosidosis mice.
Damme M, Stroobants S, Ludemann M, Rothaug M, Lullmann-Rauch R, Beck HC, Ericsson A, Andersson C, Fogh J, D'Hooge R, Saftig P, Blanz J., Ann Clin Transl Neurol 2(11), 2015
PMID: 26817023
Fucosidosis: a glycosphingolipidosis.
Dawson G, Spranger JW., N. Engl. J. Med. 285(2), 1971
PMID: 5557157
Neuromotor alterations and cerebellar deficits in aged arylsulfatase A-deficient transgenic mice.
D'Hooge R, Hartmann D, Manil J, Colin F, Gieselmann V, De Deyn PP., Neurosci. Lett. 273(2), 1999
PMID: 10505624
The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium.
Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R., J Embryol Exp Morphol 87(), 1985
PMID: 3897439
Durand P, Borrone C, Della Cella G, Liotta A., Recenti Prog Med 44(3), 1968
PMID: 4242464
Durand P, Borrone C, Della Cella G., J. Pediatr. 75(4), 1969
PMID: 4241464
Linkage of plasma alpha-L-fucosidase (FUCA2) and the plasminogen (PLG) system.
Eiberg H, Mohr J, Nielsen LS., Clin. Genet. 26(1), 1984
PMID: 6590153
Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VI.
Evers M, Saftig P, Schmidt P, Hafner A, McLoghlin DB, Schmahl W, Hess B, von Figura K, Peters C., Proc. Natl. Acad. Sci. U.S.A. 93(16), 1996
PMID: 8710849
Associations between neurologic dysfunction and lesions in canine fucosidosis.
Fletcher JL, Taylor RM., Genes Brain Behav. 15(4), 2016
PMID: 26711085
Oligodendrocyte loss during the disease course in a canine model of the lysosomal storage disease fucosidosis.
Fletcher JL, Kondagari GS, Vite CH, Williamson P, Taylor RM., J. Neuropathol. Exp. Neurol. 73(6), 2014
PMID: 24806306
MR brain imaging of fucosidosis type I.
Galluzzi P, Rufa A, Balestri P, Cerase A, Federico A., AJNR Am J Neuroradiol 22(4), 2001
PMID: 11290499
Metachromatic leukodystrophy: molecular genetics and an animal model.
Gieselmann V, Matzner U, Hess B, Lullmann-Rauch R, Coenen R, Hartmann D, D'Hooge R, DeDeyn P, Nagels G., J. Inherit. Metab. Dis. 21(5), 1998
PMID: 9728336
The core-specific lysosomal alpha(1-6)-mannosidase activity depends on aspartamidohydrolase activity.
Haeuw JF, Grard T, Alonso C, Strecker G, Michalski JC., Biochem. J. 297 ( Pt 3)(), 1994
PMID: 8110182
A suspected new canine storage disease.
Hartley WJ, Canfield PJ, Donnelly TM., Acta Neuropathol. 56(3), 1982
PMID: 7072491
Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy.
Hess B, Saftig P, Hartmann D, Coenen R, Lullmann-Rauch R, Goebel HH, Evers M, von Figura K, D'Hooge R, Nagels G, De Deyn P, Peters C, Gieselmann V., Proc. Natl. Acad. Sci. U.S.A. 93(25), 1996
PMID: 8962139
Potential pitfalls and solutions for use of fluorescent fusion proteins to study the lysosome.
Huang L, Pike D, Sleat DE, Nanda V, Lobel P., PLoS ONE 9(2), 2014
PMID: 24586430
Neuronal ceroid lipofuscinoses.
Jalanko A, Braulke T., Biochim. Biophys. Acta 1793(4), 2008
PMID: 19084560
Mammalian alpha-L-fucosidases.
Johnson SW, Alhadeff JA., Comp. Biochem. Physiol., B 99(3), 1991
PMID: 1769200
Lysosomal dysfunction causes neurodegeneration in mucolipidosis II 'knock-in' mice.
Kollmann K, Damme M, Markmann S, Morelle W, Schweizer M, Hermans-Borgmeyer I, Rochert AK, Pohl S, Lubke T, Michalski JC, Kakela R, Walkley SU, Braulke T., Brain 135(Pt 9), 2012
PMID: 22961545
Treatment of canine fucosidosis by intracisternal enzyme infusion.
Kondagari GS, King BM, Thomson PC, Williamson P, Clements PR, Fuller M, Hemsley KM, Hopwood JJ, Taylor RM., Exp. Neurol. 230(2), 2011
PMID: 21575633
The effects of intracisternal enzyme replacement versus sham treatment on central neuropathology in preclinical canine fucosidosis.
Kondagari GS, Fletcher JL, Cruz R, Williamson P, Hopwood JJ, Taylor RM., Orphanet J Rare Dis 10(), 2015
PMID: 26537923
Fucosidosis type 2.
Kousseff BG, Beratis NG, Strauss L, Brill PW, Rosenfield RE, Kaplan B, Hirschhorn K., Pediatrics 57(2), 1976
PMID: 814528
Ataxia is the major neuropathological finding in arylsulfatase G-deficient mice: similarities and dissimilarities to Sanfilippo disease (mucopolysaccharidosis type III).
Kowalewski B, Heimann P, Ortkras T, Lullmann-Rauch R, Sawada T, Walkley SU, Dierks T, Damme M., Hum. Mol. Genet. 24(7), 2014
PMID: 25452429
Biochemical and ultrastructural studies in a case of mucopolysaccharidosis "F" (fucosidosis).
Loeb H, Tondeur M, Jonniaux G, Mockel-Pohl S, Vamos-Hurwitz E., Helv Paediatr Acta 24(5), 1969
PMID: 4247654
Proteomics of the lysosome.
Lubke T, Lobel P, Sleat DE., Biochim. Biophys. Acta 1793(4), 2008
PMID: 18977398
Malm D., Riise H., Nilssen Ø.., 2012
Neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model.
Martins C, Hulkova H, Dridi L, Dormoy-Raclet V, Grigoryeva L, Choi Y, Langford-Smith A, Wilkinson FL, Ohmi K, DiCristo G, Hamel E, Ausseil J, Cheillan D, Moreau A, Svobodova E, Hajkova Z, Tesarova M, Hansikova H, Bigger BW, Hrebicek M, Pshezhetsky AV., Brain 138(Pt 2), 2015
PMID: 25567323
High proportion of mannosidosis and fucosidosis among lysosomal storage diseases in Cuba.
Menendez-Sainz C, Gonzalez-Quevedo A, Gonzalez-Garcia S, Pena-Sanchez M, Giugliani R., Genet. Mol. Res. 11(3), 2012
PMID: 22911605
Four year follow-up of a case of fucosidosis treated with unrelated donor bone marrow transplantation.
Miano M, Lanino E, Gatti R, Morreale G, Fondelli P, Celle ME, Stroppiano M, Crescenzi F, Dini G., Bone Marrow Transplant. 27(7), 2001
PMID: 11360116
Characterization and 400-MHz 1H-NMR analysis of urinary fucosyl glycoasparagines in fucosidosis.
Michalski JC, Wieruszeski JM, Alonso C, Cache P, Montreuil J, Strecker G., Eur. J. Biochem. 201(2), 1991
PMID: 1935941
Histomorphologic and histochemical investigations in mannosidosis. A light and electron microscopic study
Monus Z., Konyar E., Szabo L.., 1977
Analysis of the subunits, isoforms and substrate specificity of mouse liver alpha-L-fucosidase.
Shoarinejad F, Johnson SW, Alhadeff JA., Comp. Biochem. Physiol., B 105(1), 1993
PMID: 8504637
Targeted disruption of the lysosomal alpha-mannosidase gene results in mice resembling a mild form of human alpha-mannosidosis.
Stinchi S, Lullmann-Rauch R, Hartmann D, Coenen R, Beccari T, Orlacchio A, von Figura K, Saftig P., Hum. Mol. Genet. 8(8), 1999
PMID: 10400983
[Structures of 9 oligosaccharides and glycopeptides containing large amounts of fucose excreted in the urine of 2 patients with fucosidosis].
Strecker G, Fournet B, Spik G, Montreuil J, Durand P, Tondeur M., C.R. Hebd. Seances Acad. Sci., Ser. D, Sci. Nat. 284(1), 1977
PMID: 402234
Early signs of neurolipidosis-related behavioural alterations in a murine model of metachromatic leukodystrophy.
Stroobants S, Leroy T, Eckhardt M, Aerts JM, Berckmans D, D'Hooge R., Behav. Brain Res. 189(2), 2008
PMID: 18336930
Amelioration of clinical disease following bone marrow transplantation in fucosidase-deficient dogs.
Taylor RM, Farrow BR, Stewart GJ., Am. J. Med. Genet. 42(4), 1992
PMID: 1609845
Structure of the accumulating oligosaccharide in fucosidosis.
Tsay GC, Dawson G, Sung SS., J. Biol. Chem. 251(19), 1976
PMID: 972144
Mucopolysaccharidosis by absence of alpha-fucosidase.
Van Hoof F, Hers HG., Lancet 1(7553), 1968
PMID: 4172303
Common and uncommon pathogenic cascades in lysosomal storage diseases.
Vitner EB, Platt FM, Futerman AH., J. Biol. Chem. 285(27), 2010
PMID: 20430897
Secondary accumulation of gangliosides in lysosomal storage disorders.
Walkley SU., Semin. Cell Dev. Biol. 15(4), 2004
PMID: 15207833
Secondary lipid accumulation in lysosomal disease.
Walkley SU, Vanier MT., Biochim. Biophys. Acta 1793(4), 2008
PMID: 19111580
[Effect of the injection of Triton WR 1339 on the hepatic lysosomes of the rat.]
WATTIAUX R, WIBO M, BAUDHUIN P., Arch. Int. Physiol. Biochim. 71(), 1963
PMID: 13999241
Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB.
Wilkinson FL, Holley RJ, Langford-Smith KJ, Badrinath S, Liao A, Langford-Smith A, Cooper JD, Jones SA, Wraith JE, Wynn RF, Merry CL, Bigger BW., PLoS ONE 7(4), 2012
PMID: 22558223
Fucosidosis revisited: a review of 77 patients.
Willems PJ, Gatti R, Darby JK, Romeo G, Durand P, Dumon JE, O'Brien JS., Am. J. Med. Genet. 38(1), 1991
PMID: 2012122
Urinary glycopeptides of fucosidosis.
Yamashita K, Tachibana Y, Takada S, Matsuda I, Arashima S, Kobata A., J. Biol. Chem. 254(11), 1979
PMID: 438217

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

PMID: 27491075
PubMed | Europe PMC

Suchen in

Google Scholar